The lipid profile in psoriasis: a controlled study

被引:79
作者
Akhyani, M. [1 ]
Ehsani, A. H. [1 ]
Robati, R. M. [1 ]
Robati, A. M. [1 ]
机构
[1] Univ Tehran, Razi Hosp, Dept Dermatol, Tehran, Iran
关键词
lipid; psoriasis; serum;
D O I
10.1111/j.1468-3083.2007.02260.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Psoriasis is an inflammatory dermatosis that is characterized with hyperproliferation of keratinocytes and inflammatory infiltration in the epidermis and dermis. The high prevalence of atherosclerosis has been reported in psoriatic patients. High serum lipid level has been suggested in the pathogenesis of this phenomenon. In this study, our purpose was to compare the lipid profile in psoriatic patients with non-affected persons. Methods: This study was designed and conducted as a case-control assay with 50 cases in the patient and control groups, respectively. The lipid profile, including serum level of triglyceride, cholesterol, low-density lipoprotein (LDL), and high-density lipoprotein (HDL), were assessed in both groups. Results: The patient and control groups each consisted of 50 cases (39 male and 11 female). The serum triglyceride, cholesterol, and LDL was significantly higher in psoriatic patients (P < 0.05) but not for HDL (P = 0.29). Conclusion: This study, like previous assays, shows that high serum lipid level is significantly more common in psoriasis. This fact may be responsible for higher prevalence of cardiovascular accident in psoriatic patients. It may be useful to do early screening and treatment of hyperlipidaemia in psoriasis to prevent the atherosclerosis and its complications.
引用
收藏
页码:1330 / 1332
页数:3
相关论文
共 17 条
  • [1] Impaired clearance of apoptotic cells promotes synergy between atherogenesis and autoimmune disease
    Aprahamian, T
    Rifkin, I
    Bonegio, A
    Hugel, B
    Freyssinet, JM
    Sato, K
    Castellot, JJ
    Walsh, K
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (08) : 1121 - 1131
  • [2] Cytokine expression in advanced human atherosclerotic plaques:: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines
    Frostegård, J
    Ulfgren, AK
    Nyberg, P
    Hedin, U
    Swedenborg, J
    Andersson, U
    Hansson, GK
    [J]. ATHEROSCLEROSIS, 1999, 145 (01) : 33 - 43
  • [3] GURKOK F, 1999, B LEPROSY, V30, P105
  • [4] Evaluation of the atherogenic tendency of lipids and lipoprotein content and their relationships with oxidant-antioxidant system in patients with psoriasis
    Kural, BV
    Örem, A
    Çimsit, G
    Yandi, YE
    Calapoglu, M
    [J]. CLINICA CHIMICA ACTA, 2003, 328 (1-2) : 71 - 82
  • [5] Psoriasis is associated with lipid abnormalities at the onset of skin disease
    Mallbris, L
    Granath, F
    Hamsten, A
    Ståhle, M
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (04) : 614 - 621
  • [6] Pietrzak A, 1998, Ann Univ Mariae Curie Sklodowska Med, V53, P187
  • [7] Pietrzak Aldona, 2002, Med Sci Monit, V8, pCR9
  • [8] Serum lipid levels in psoriasis
    Piskin, S
    Gurkok, F
    Ekuklu, G
    Senol, M
    [J]. YONSEI MEDICAL JOURNAL, 2003, 44 (01) : 24 - 26
  • [9] CUTANEOUS SIDE-EFFECTS OF LIPID-LOWERING AGENTS
    PROKSCH, E
    [J]. HAUTARZT, 1995, 46 (02): : 76 - 80
  • [10] Lipid profile, insulin secretion, and insulin sensitivity in psoriasis
    Reynoso-von Drateln, C
    Martínez-Abundis, E
    Balcázar-Muñoz, BR
    Bustos-Saldaña, R
    González-Ortiz, M
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2003, 48 (06) : 882 - 885